Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 12/12/2018
SIETES contiene 92610 citas

<< anterior 21 a 40 de 194 siguiente >>
Presentar resultados
Seleccionar todas
21.Tiene citas relacionadas Cita con resumen
Rutter MK, Wright AK, Ashcroft DM. Sitagliptin and cardiovascular outcomes in type 2 diabetes. N Engl J Med 2015;373:2478. [Ref.ID 99761]
22. Cita con resumen
Andersen NN, Pasternak B, Andersson M, Nielsen NM, Jess T. Risk of demyelinating diseases in the central nervous system in patients with inflammatory bowel disease treated with tumor necrosis factor inhibitors. JAMA Intern Med 2015;175:1990-2. [Ref.ID 99751]
23.Tiene citas relacionadas Cita con resumen
Wang C, Graham DJ, Kane RC, Xie D, Wemecke M, Levenson M, MaCurdy TE, Houstoun M, Ryan Q, Wong S, Mott K, Sheu T-C, Limb S, Worrall C, Kelman JA, Reichman ME. Comparative risk of anaphylactic reactions associated with intravenous iron products. JAMA 2015;314:2062-8. [Ref.ID 99687]
24.Tiene citas relacionadas Cita con resumen
Fournier JP, Azoulay L, Yin H, Montastruc J-L, Suissa S. Tramadol use and the risk of hospitalization for hypoglycemia in patients with noncancer pain. JAMA Intern Med 2014;175:186-93. [Ref.ID 98791]
25. Cita con resumen
Li DQ, Kim R, McArthur E, Fleet JL, Bailey DG, Juurlink D, Shariff SZ, Gomes T, Mamdani M, Gandhi S, Dixon S, Garg AX. Risk of adverse events among older adults following co-prescription of clarithromycin and statins not metabolized by cytochrome P450 3A4. Can Med Assoc J 2015;187:174-80. [Ref.ID 98758]
26. Cita con resumen
Lamberts M, Lip GYH, Hansen ML, Lindhardsen J, Olesen JB, Raunso J, Schjerning Olsen A-M, Andersen PK, Gerds TA, Nat R, Fosbol EL, Torp-Pedersen C. Relation of nonsteroidal anti-inflammatory drugs to serious bleeding and thromboembolism risk in patients with atrial fibrillation receiving antithrombotic therapy: a nationwide cohort study. Ann Intern Med 2014;161:690-8. [Ref.ID 98326]
27.Tiene citas relacionadas Cita con resumen
28. Cita con resumen
Weich S, Pearce HL, Croft P, Singh S, Crome I, Bashford J, Frisher M. Effect of anxiolytic and hypnotic drug prescriptions on mortality hazards: retrospective cohort study. BMJ 2014;348:g1996. [Ref.ID 97297]
30.Tiene citas relacionadas Cita con resumen
31. Cita con resumen
Spencer FA, Iorio A, You J, Murad MH, Schünemann HJ, Vandvik PO, Crowther MA, Pottie K, Lang ES, Meerpohl JJ, Falck-Ytter Y, Alonso-Coello P, Guyatt GH. Uncertainties in baseline risk estimates and confidence in treatment effects. BMJ 2012;345:18-21. [Ref.ID 94177]
33.Tiene citas relacionadas Cita con resumen
Herzig S, Rothberg M. Drug prophylaxis in general medical patients: does usage reflect the benefits and risks?. BMJ 2012;344:21-3. [Ref.ID 93191]
34. Cita con resumen
Asbridge M, Hayden JA, Cartwright JL. Acute cannabis consumption and motor vehicle collision risk: systematic review of observational studies. BMJ 2012;344:14. [Ref.ID 92505]
35. Cita con resumen
Hall W. Driving while under the influence of cannabis. BMJ 2012;344:7. [Ref.ID 92504]
36. Cita con resumen
Moynihan R. Surrogates under scrutiny: fallible correlations, fatal consequences. BMJ 2011;343:d5160. [Ref.ID 91893]
37. Cita con resumen
Anónimo. Lenalidomide (Revlimid): risk of secondary primary malignancy - update. Drug Safety Update 2011;5:1-2. [Ref.ID 91625]
38. Cita con resumen
Bolland MJ, Grey A. Data openness. Reporting of absolute risk. BMJ 2010;341:1063. [Ref.ID 89685]
39.Tiene citas relacionadas
Kleijer BC, Heerdink ER, van Marum RJ. Antipsychotics and venous thrombosis. Dutch experience differs. BMJ 2010;341:793. [Ref.ID 89507]
Seleccionar todas
<< anterior 21 a 40 de 194 siguiente >>